These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 26972377)
1. Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel. Yu D; Sun C; Zheng Z; Wang X; Chen D; Wu H; Wang X; Shi F Int J Pharm; 2016 Apr; 503(1-2):229-37. PubMed ID: 26972377 [TBL] [Abstract][Full Text] [Related]
2. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity. Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676 [No Abstract] [Full Text] [Related]
3. A novel controlled local drug delivery system for inner ear disease. Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968 [TBL] [Abstract][Full Text] [Related]
4. Silk-coated dexamethasone non-spherical microcrystals for local drug delivery to inner ear. Li M; Ai M; Yang Y; Yao X; Zhou Z; Wang H; Li C; Xu K Eur J Pharm Sci; 2020 Jul; 150():105336. PubMed ID: 32360767 [TBL] [Abstract][Full Text] [Related]
5. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Wang X; Dellamary L; Fernandez R; Harrop A; Keithley EM; Harris JP; Ye Q; Lichter J; LeBel C; Piu F Audiol Neurootol; 2009; 14(6):393-401. PubMed ID: 19923809 [TBL] [Abstract][Full Text] [Related]
6. Assessment of PLGA-PEG-PLGA copolymer hydrogel for sustained drug delivery in the ear. Feng L; Ward JA; Li SK; Tolia G; Hao J; Choo DI Curr Drug Deliv; 2014; 11(2):279-86. PubMed ID: 24438444 [TBL] [Abstract][Full Text] [Related]
7. Silk fibroin hydrogel/dexamethasone sodium phosphate loaded chitosan nanoparticles as a potential drug delivery system. Akrami-Hasan-Kohal M; Eskandari M; Solouk A Colloids Surf B Biointerfaces; 2021 Sep; 205():111892. PubMed ID: 34107443 [TBL] [Abstract][Full Text] [Related]
8. A silk-based hydrogel containing dexamethasone and lipoic acid microcrystals for local delivery to the inner ear. Xiong H; Zhang P; Wang D; Zhou Z; Sun J; Diao M Colloids Surf B Biointerfaces; 2024 May; 237():113855. PubMed ID: 38513298 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid liposomal gel sustains delivery of a corticoid to the inner ear. El Kechai N; Mamelle E; Nguyen Y; Huang N; Nicolas V; Chaminade P; Yen-Nicolaÿ S; Gueutin C; Granger B; Ferrary E; Agnely F; Bochot A J Control Release; 2016 Mar; 226():248-57. PubMed ID: 26860286 [TBL] [Abstract][Full Text] [Related]
10. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Piu F; Wang X; Fernandez R; Dellamary L; Harrop A; Ye Q; Sweet J; Tapp R; Dolan DF; Altschuler RA; Lichter J; LeBel C Otol Neurotol; 2011 Jan; 32(1):171-9. PubMed ID: 21099726 [TBL] [Abstract][Full Text] [Related]
11. Silk fibroin/copolymer composite hydrogels for the controlled and sustained release of hydrophobic/hydrophilic drugs. Zhong T; Jiang Z; Wang P; Bie S; Zhang F; Zuo B Int J Pharm; 2015 Oct; 494(1):264-70. PubMed ID: 26283278 [TBL] [Abstract][Full Text] [Related]
12. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window]. Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254 [TBL] [Abstract][Full Text] [Related]
13. Covalent incorporation and controlled release of active dexamethasone from injectable polyethylene glycol hydrogels. Bezuidenhout D; Oosthuysen A; Davies N; Ahrenstedt L; Dobner S; Roberts P; Zilla P J Biomed Mater Res A; 2013 May; 101(5):1311-8. PubMed ID: 23065782 [TBL] [Abstract][Full Text] [Related]
14. Novel strategy for treatment of inner ears using a biodegradable gel. Endo T; Nakagawa T; Kita T; Iguchi F; Kim TS; Tamura T; Iwai K; Tabata Y; Ito J Laryngoscope; 2005 Nov; 115(11):2016-20. PubMed ID: 16319616 [TBL] [Abstract][Full Text] [Related]
15. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease. Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491 [TBL] [Abstract][Full Text] [Related]
16. A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration. Sun C; Wang X; Zheng Z; Chen D; Wang X; Shi F; Yu D; Wu H Int J Nanomedicine; 2015; 10():3567-79. PubMed ID: 25999718 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of silk fibroin hydrogel as injectable implants for sustained release of Risperidone. Ebrahimi A; Sadrjavadi K; Hajialyani M; Shokoohinia Y; Fattahi A Drug Dev Ind Pharm; 2018 Feb; 44(2):199-205. PubMed ID: 28956466 [TBL] [Abstract][Full Text] [Related]
19. Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy. Yang KJ; Son J; Jung SY; Yi G; Yoo J; Kim DK; Koo H Biomaterials; 2018 Jul; 171():133-143. PubMed ID: 29689410 [TBL] [Abstract][Full Text] [Related]
20. Development of thermosensitive poloxamer 407-based microbubble gel with ultrasound mediation for inner ear drug delivery. Liao AH; Shih CP; Li MW; Lin YC; Chuang HC; Wang CH Drug Deliv; 2021 Dec; 28(1):1256-1271. PubMed ID: 34142922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]